News | December 05, 2023
Cupid acquires land parcel near Mumbai
The acquisition will enable Cupid Limited to amplify its production capacity by 1.5 times the existing output
The acquisition will enable Cupid Limited to amplify its production capacity by 1.5 times the existing output
The extension builds upon an existing long-term collaboration for end-to-end ADC manufacturing, including payload, monoclonal antibody (mAb) manufacturing and bioconjugation
CMOs showed an increasing reluctance to take on debt in 2022
Total investments could reach €70 million, of which approximately 15% in R&D and 85% in capex, that would be deployed from 2026
New facility will strengthen the security of supply for global pharmaceutical and biotech customers and will support the continued development and production of lifesaving clinical and commercial-scale therapeutics for patients worldwide.
The development and deployment of effective vaccines can help to mitigate the impact of pandemics, and we must prioritize research efforts to achieve this objective
Specialty Chemicals grew 38% YoY for FY23
The expansion program includes investments in France and the U.S., adding an additional 23,000+ m² of manufacturing footprint.
Once the unit is made fully functional, it will help the company in increasing its API and intermediate production capacity
Pharmaceutical sales de-grew 18% YoY and stood at Rs. 224 crore whereas Crop Protection sales de-grew by 15% at Rs. 154 crore
Subscribe To Our Newsletter & Stay Updated
